Development of An Electronic Decision Tool To Support Appropriate Treatment Choice in Epilepsy
Germaine Van Rijckevorsel, Herman Stoevelaar(Barnes-Jewish Hospital), Berten Ceulemans(University of Antwerp), Thomas Coppens, B. Legros, Karine Geens, A. Mignon, Michel Ossemann, Lieven Lagae(Allen Institute for Brain Science), Michel Van Zandijcke, Paul Boon(Ghent University Hospital), L. P. Mol, Henri Hauman, Thierry Grisar(University of Liège), Pascal Vrielynck
Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B))
January 1, 2008
Cited by 0
Related Papers
Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study
|The Lancet Neurology|2013|1.1k
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial
|The Lancet|2019|361
A deletion in <i>SCN1B</i> is associated with febrile seizures and early-onset absence epilepsy
|Neurology|2003|167
A novel <i>GABRG2</i> mutation associated with febrile seizures
|Neurology|2006|157